117 related articles for article (PubMed ID: 15276860)
1. Canine lymphomas: a morphological and immunohistochemical study of 55 cases, with observations on p53 immunoexpression.
Sueiro FA; Alessi AC; Vassallo J
J Comp Pathol; 2004; 131(2-3):207-13. PubMed ID: 15276860
[TBL] [Abstract][Full Text] [Related]
2. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
4. p53 oncoprotein expression in cutaneous lymphoproliferations.
Beylot-Barry M; Vergier B; DeMascarel A; Beylot C; Merlio JP
Arch Dermatol; 1995 Sep; 131(9):1019-24. PubMed ID: 7661603
[TBL] [Abstract][Full Text] [Related]
5. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
[TBL] [Abstract][Full Text] [Related]
7. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and immunophenotypical features of canine intravascular lymphoma (malignant angioendotheliomatosis).
McDonough SP; Van Winkle TJ; Valentine BA; vanGessel YA; Summers BA
J Comp Pathol; 2002 May; 126(4):277-88. PubMed ID: 12056776
[TBL] [Abstract][Full Text] [Related]
9. Extranodal malignant lymphoma of the upperaerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification.
Assanasen T; Wannakrairot P; Keelawat S; Pramprayoon N; Chaipipat M
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S249-54. PubMed ID: 16083197
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
11. [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study].
Meneses-García A; Herrera J; Mohar A; García-Cuellar C; Súchil-Bernal L
Gac Med Mex; 2005; 141(4):291-6. PubMed ID: 16164124
[TBL] [Abstract][Full Text] [Related]
12. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
13. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
Krivolapov IuA
Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
[TBL] [Abstract][Full Text] [Related]
14. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study.
Connor J; Ashton-Key M
Histopathology; 2007 Nov; 51(5):697-703. PubMed ID: 17927592
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical and serological determination of p53 protein in patients with malignant lymphomas.
Jezersek-Novaković B; Frković-Grazio S; Novaković S
Neoplasma; 2002; 49(1):16-20. PubMed ID: 12044054
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
17. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
19. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Paik JH; Jeon YK; Park SS; Kim YA; Kim JE; Huh J; Lee SS; Kim WH; Kim CW
Histopathology; 2005 Sep; 47(3):281-91. PubMed ID: 16115229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]